Skip to main content
    D

    Dolby Laboratories (DLB)

    Official site

    INDUSTRIALS • SPECIALTY BUSINESS SERVICES • NYSE

    $61.16
    -2.46 (-3.86%)

    Market Cap: $5.96B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Dolby Laboratories (DLB) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Dolby Laboratories (DLB) trades at 15.9x trailing earnings and 4.3x sales. Its P/E of 15.9x is below its 5-year median of 21.7x. Its forward P/E is 13.8x. The median P/E across 11 similar companies is 21.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 15.2% higher over the next year. Its free cash flow yield is 6.8%.

    MultipleValue
    P/E (trailing)15.9x
    Forward P/E13.8x
    Price to sales4.3x
    Price to book2.2x
    EV/EBITDA14.1x
    Price to FCF14.7x
    EV/FCF13.0x
    PEG2.1
    FCF yield6.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 28.4% below 22.2x, its P/S is 20.4% below 5.4x and its P/B is 26.7% below 3.0x.

    MultipleCurrent5-year median10-year median
    P/E15.9x21.7x22.2x
    P/S4.3x5.9x5.4x
    P/B2.2x3.0x3.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 15.4x in 2025 to 29.7x in 2021. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$64.2215.4x4.6x2.4x
    2024$78.1019.9x5.7x3.0x
    2023$86.1824.8x6.5x3.5x
    2022$70.5421.7x5.6x3.0x
    2021$95.2229.7x7.8x3.7x
    2020$97.1325.4x7.8x3.8x
    2019$68.8024.0x5.7x3.0x
    2018$61.8421.5x3.1x2.7x
    2017$62.0022.7x2.9x3.1x
    2016$45.1917.3x4.4x2.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DLB

    What is DLB's forward P/E ratio?

    Dolby Laboratories has a forward P/E ratio of 13.8x.

    Is DLB stock overvalued?

    GNG's valuation label for DLB is Undervalued. Its P/E of 15.9x compares with a median of 21.4x across 11 similar companies.

    What is DLB's price to sales ratio?

    Dolby Laboratories has a price to sales ratio of 4.3x.

    What is Dolby Laboratories's average P/E ratio over 5 years?

    Dolby Laboratories's median P/E over the last 5 years is 21.7x, from 60 month-end values through Oct 2026.

    What is DLB's PEG ratio?

    Dolby Laboratories has a PEG ratio of 2.1.